Alt desc U.S. Department of Health & Human Services Alt descAlt desc National Institutes of Health Alt desc
Skip Over Navigation Links
In a mouse model of Alzheimer’s disease, amyloid beta clusters (red) build up among neurons (green) in a memory-related area of the brain. (Credit: Strittmatter Laboratory, Yale University Photo/Adam Kaufman)

Repurposing a Cancer Treatment for Alzheimer’s Disease

NCATS support to Yale team leads to expedited clinical trial to test experimental drug as Alzheimer's treatment.

Work with Us

NCATS pre-clinical programs and resources focus on key obstacles and inefficiencies in the translational process, overcoming bottlenecks that slow the development of new treatments for patients.

Learn more about how to access NCATS programs and expertise.

Pre-Clinical Innovation

NCATS develops novel approaches to improve the process of joining basic science discoveries with initial testing of therapies in humans. 

Find NCATS Programs & InitiativesAccess NCATS Expertise & Resources

Improving the Drug Development Process

Creating and testing innovative methods to improve and accelerate the drug development process and find new treatments for patients faster.

Repurposing Drugs

Discovering new uses for approved drugs to provide the quickest possible transition from bench to bedside.

Testing & Predictive Models

Developing better model systems for drug and toxicity testing.

Core Technologies

Using state-of-the-art resources to enable the ongoing operation of all NCATS translational research activities.